Suppr超能文献

关于长期使用万古霉素产生耐药性风险的观察

Observations on the risk of resistance with the extended use of vancomycin.

作者信息

McManus A T, Goodwin C W, Pruitt B A

机构信息

US Army Institute of Surgical Research, Fort Sam Houston, Tex 78234-6315, USA.

出版信息

Arch Surg. 1998 Nov;133(11):1207-11. doi: 10.1001/archsurg.133.11.1207.

Abstract

OBJECTIVE

To document the risk of the development of vancomycin-resistant bacteria in a population of seriously burned patients during a 10-year period of common vancomycin hydrochloride use.

DESIGN

Retrospective study.

SETTING

The US Army Institute of Surgical Research, Burn Center, Fort Sam Houston, Tex.

POPULATION AND METHODS

Microbiology, infection, and antibiotic use records collected during the hospitalization of 2266 consecutively admitted seriously burned patients were reviewed. Vancomycin was the primary therapeutic agent used for gram-positive infections and was also used as a perioperative prophylactic antibiotic during burn wound excision. This policy was established prior to this review because of a high incidence of methicillin-resistant Staphylococcus aureus colonization and an anecdotal association of increased beta-lactam resistance in endemic gram-negative pathogens associated with the use of penicillinase-resistant penicillins and cephalosporins.

MAIN OUTCOME MEASURES

Isolation of vancomycin-resistant enterococci (VRE) or other gram-positive organisms resistant to vancomycin.

RESULTS

Examinations of 15 125 gram-positive isolates, including 957 enterococci, for in vitro sensitivity to vancomycin yielded 3 VRE isolates in 3 patients. Vancomycin was used prior to VRE isolation in one of these patients. Resistance was found in 3 other organisms (2 Corynebacterium species, 1 Lactobacillus species). Vancomycin was used prior to these isolations in 2 of 3 patients. None of the vancomycin-resistant organisms was associated with infection and all 6 patients survived. Vancomycin-resistant enterococci or other vancomycin-resistant gram-positive organisms were not found in 663 patients treated with vancomycin for documented gram-positive infections or in 1027 patients where perioperative vancomycin was used.

CONCLUSION

Use of vancomycin as the primary therapeutic agent in seriously burned patients was not associated with increased risk of VRE isolation or VRE infection.

摘要

目的

记录在10年期间普通使用盐酸万古霉素的严重烧伤患者群体中出现耐万古霉素细菌的风险。

设计

回顾性研究。

地点

美国德克萨斯州萨姆休斯顿堡外科研究所陆军烧伤中心。

研究对象和方法

回顾了2266例连续入院的严重烧伤患者住院期间收集的微生物学、感染和抗生素使用记录。万古霉素是用于革兰氏阳性菌感染的主要治疗药物,也用作烧伤创面切除术中的围手术期预防性抗生素。由于耐甲氧西林金黄色葡萄球菌定植的高发生率以及与使用耐青霉素酶青霉素和头孢菌素相关的地方性革兰氏阴性病原体中β-内酰胺耐药性增加的传闻关联,在本次回顾之前制定了该政策。

主要观察指标

分离出耐万古霉素肠球菌(VRE)或其他对万古霉素耐药的革兰氏阳性菌。

结果

对15125株革兰氏阳性菌分离株(包括957株肠球菌)进行万古霉素体外敏感性检测,在3例患者中分离出3株VRE。其中1例患者在分离出VRE之前使用了万古霉素。在另外3种微生物(2种棒状杆菌属、1种乳酸杆菌属)中发现了耐药性。3例患者中有2例在分离出这些微生物之前使用了万古霉素。所有耐万古霉素的微生物均与感染无关,6例患者全部存活。在663例因记录在案的革兰氏阳性菌感染而使用万古霉素治疗的患者或1027例使用围手术期万古霉素的患者中,未发现耐万古霉素肠球菌或其他耐万古霉素的革兰氏阳性菌。

结论

在严重烧伤患者中使用万古霉素作为主要治疗药物与VRE分离或VRE感染风险增加无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验